KUALA LUMPUR - China's control of the base ingredients to make medicines gives the Asian giant leverage over the production of a coronavirus vaccine no matter who wins the global race to discover it.
This could give Beijing a crucial advantage even as tensions with Washington have intensified during the Covid-19 outbreak amid a blame game over the cause of the highly infectious disease that has put more than half of humanity into various levels of lockdown. China also holds a near-monopoly further upstream on thousands of key starting materials such as chemical intermediates and ingredients from antibiotic fermentation plants and pigs. The Asian superpower's pharmaceutical industry has benefited in the past from cornering the supply chain by increasing manufacturing capacity and what Ms Gibson said were cartel-like practices such as price-fixing.
However, concerns over Beijing holding the world to ransom could be tempered by the inter-dependence on trade for healthcare goods used in fighting the coronavirus.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: TODAYonline - 🏆 1. / 99 Read more »